These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6513749)

  • 21. Recent progress in radiation oncology.
    Tubiana M
    Prog Clin Biol Res; 1983; 132A():107-31. PubMed ID: 6634742
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumors.
    Fenton BM; Paoni SF; Ding I
    Cancer Res; 2004 Aug; 64(16):5712-9. PubMed ID: 15313911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growting points in mammalian radiobiology and their implications for radiothrapy.
    Berry RJ
    Radiol Clin North Am; 1969 Aug; 7(2):281-92. PubMed ID: 4980614
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimum fractionation in X-ray treatment of C3H mouse mammary tumours.
    Fowler JF; Denekamp J; Sheldon PW; Smith AM; Begg AC; Harris SR; Page AL
    Br J Radiol; 1974 Nov; 47(563):781-9. PubMed ID: 4434003
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental particle radiation therapy in animal neoplasia. I. Electron versus roentgen irradiation.
    Lippincott SW; Montour JL; Wilson JD; Cohn S; Flora RE
    Acta Radiol Ther Phys Biol; 1973 Dec; 12(6):541-51. PubMed ID: 4787172
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the biological behaviour of mamma carcinoma of C3H-mouse in hyperfractionation (author's transl)].
    Kob D; Kloetzer KH; Arndt J; Kriester A; Magdon E
    Radiobiol Radiother (Berl); 1976; 17(5):589-96. PubMed ID: 1019307
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: Optimum fractionation in X-ray treatment of C3H mouse mammary tumours.
    Fowler JF; Denekamp J; Sheldon PW; Smith AM; Begg AC; Harris SR; Page AL
    Br J Radiol; 1974 Jun; 47(558):365. PubMed ID: 4835220
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modern radiation therapy: the achievements and outlook].
    Boĭko AV; Goldobenko GV; Kanaev SV; Kostromina KN; Mardynskiĭ IuS; Musabaeva LI; Rubtsov VR
    Vopr Onkol; 1995; 41(2):83-90. PubMed ID: 7483453
    [No Abstract]   [Full Text] [Related]  

  • 29. [Artificial enteral nutrition as a supportive measure in simultaneous radiotherapy].
    Freund U; Knüfermann H
    Beitr Infusionther Klin Ernahr; 1986; 14():143-5. PubMed ID: 3096281
    [No Abstract]   [Full Text] [Related]  

  • 30. [Radiotherapy. Biological and technical basis].
    Tubiana M; Pierquin B
    Rev Prat; 1972 Nov; 22(28):3793-801. PubMed ID: 4630816
    [No Abstract]   [Full Text] [Related]  

  • 31. An update of pediatric radiation oncology.
    Macklis RM; Tarbell NJ
    Semin Pediatr Surg; 1993 Feb; 2(1):19-28. PubMed ID: 8062018
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of irradiation on the mammary carcinoma of the dog. Experimental study on the effect of properative radiation therapy and the question of radiation resistance of tumors after subliminal radiation effects].
    Möbius W; Böhm W
    Arch Geschwulstforsch; 1969; 33(1):5-17. PubMed ID: 5401487
    [No Abstract]   [Full Text] [Related]  

  • 33. Radiation dose fractionation and tumor control probability.
    Suit H; Wette R
    Radiat Res; 1966 Oct; 29(2):267-81. PubMed ID: 5924745
    [No Abstract]   [Full Text] [Related]  

  • 34. [5-year results of radiation therapy under hyperbaric oxygenation in malignant tumors].
    Kiseleva ES; Dar'ialova SP; Volkova MA; Kuznetsova IP; Falileeva EP
    Med Radiol (Mosk); 1981 Sep; 26(9):3-11. PubMed ID: 7300614
    [No Abstract]   [Full Text] [Related]  

  • 35. Radiation as a therapeutic modality in sarcomas of the soft tissue.
    Suit H; Spiro I
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):733-46. PubMed ID: 7490238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cancer and radiotherapy(3). Radiobiology for radiotherapy].
    Ando K
    Iyodenshi To Seitai Kogaku; 1982 Apr; 20(2):122-9. PubMed ID: 6752496
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radiobiology of injuries of the pelvic structures].
    Magno L
    Arch Ital Urol Nefrol Androl; 1988 Dec; 60(4):353-5. PubMed ID: 2977663
    [No Abstract]   [Full Text] [Related]  

  • 39. Possibility of using an alkylating agent in radiotherapy of mammary carcinoma in C3H-He mice.
    Urano M; Tanaka N; Hayashi S
    Gan; 1972 Aug; 63(4):491-4. PubMed ID: 5081625
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of fractionated doses of neutrons on C3H mouse mammary tumours.
    Fowler JF; Field SB; Denekamp J
    Eur J Cancer (1965); 1974 May; 10(5):281-5. PubMed ID: 4442430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.